A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study

Volume: 66, Issue: 1, Pages: S33 - S34
Published: Jan 1, 2017
Abstract
No abstract.
Paper Details
Title
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study
Published Date
Jan 1, 2017
Volume
66
Issue
1
Pages
S33 - S34
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.